{
  "url": "https://pubmed.ncbi.nlm.nih.gov/41125873/?fc=None&ff=20251031173411&v=2.18.0.post22+67771e2",
  "title": "Author Correction: An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer - PubMed",
  "description": "An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.    Chen M, Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J, Katon JM, Menon AV,...",
  "links": [
    "https://pubmed.ncbi.nlm.nih.gov/41125873/?fc=None&ff=20251031173411&v=2.18.0.post22+67771e2"
  ],
  "image": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg",
  "content": "<div>\n    <li>\n  <div>\n    <p><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/29335545/\">\n        An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.\n    </a></p><p><span>Chen M, Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J, Katon JM, Menon AV, Webster KA, Ng C, Palumbieri MD, Diolombi MS, Breitkopf SB, Teruya-Feldstein J, Signoretti S, Bronson RT, Asara JM, Castillo-Martin M, Cordon-Cardo C, Pandolfi PP.</span>\n    <span>Chen M, et al.</span>\n    <span>Nat Genet. 2018 Feb;50(2):206-218. doi: 10.1038/s41588-017-0027-2. Epub 2018 Jan 15.</span>\n    <span>Nat Genet. 2018.</span>\n  <span>PMID: <span>29335545</span></span>\n  <span>Free PMC article.</span>\n</p>\n  </div>\n    </li>\n        </div>",
  "author": "",
  "favicon": "https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png",
  "source": "pubmed.ncbi.nlm.nih.gov",
  "published": "",
  "ttr": 16,
  "type": "website"
}